Month February 2016

2016 Alzheimer Europe Conference opens call for abstracts

Alzheimer Europe and Alzheimerforeningen are now accepting abstracts for the 26th Alzheimer Europe Conference, which will take place from October 31 – November 2, 2016, in Copenhagen, Denmark. Abstracts for oral and poster presentations can be submitted in the following…

A better model for Parkinson’s

Scientists have solved a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development. Parkinson’s disease is characterized by the appearance of…

Alzheimer’s disease: a new immunotherapy approach?

A study conducted on mice offers a new type of immunotherapy approach for treating Alzheimer’s disease. This involves amplifying a specific population of T lymphocytes that regulate immune and neuroinflammatory mechanisms that develop during the disease. These results are published…

Novel factor in Parkinson’s disease discovered

A team of researchers has discovered a previously unknown cellular defect in patients with idiopathic Parkinson’s disease, and identified a sequence of pathological events that can trigger or accelerate premature death of certain neurons in the brain seen in this…

Alzheimer’s plaques found in brains of middle-aged TBI patients

Scientists have revealed that protein clumps associated with Alzheimer’s disease are also found in the brains of people who have had a head injury. Although previous research has shown that these clumps, called amyloid plaques, are present shortly after a…

Delivering genes across the blood-brain barrier

Caltech biologists have modified a harmless virus in such a way that it can successfully enter the adult mouse brain through the bloodstream and deliver genes to cells of the nervous system. The virus could help researchers map the intricacies…

Researchers learn how dopamine transports within the brain

Researchers have discovered the mechanics of how dopamine transports into and out of brain cells, a finding that could someday lead to more effective treatment of drug addictions and neurological disorders such as Parkinson’s disease. The research was done by…

Parkinson’s disease: New insights into a traveling protein

A laboratory study indicates that the main protein involved in Parkinson’s disease pathology does not behave as a prion when overexpressed. In Parkinson’s disease, the protein alpha-synuclein aggregates within neurons of patients and appears to propagate across interconnected areas of…

Post
Filter